Quality manager in a work-study program at the IUT of Toulon, I am in charge of the implementation of the quality and information security management system in relation with the biomedical imaging and research and development activities. With a degree … Read More
Ventio participates to the follow-up of Alzheimer’s disease patients by offering a patented, innovative and quantitative technology for the follow-up of neuronal lesions by cerebral imaging: the Quantitative Susceptibility Mapping (QSM) technology. Ventio, with the QSM technology, is alongside … Read More
Association Française des Correspondants à la Protection des Données à Caractère Personnel (AFCDP)
CTO & Medical director Stephane Roche Researcher, Stéphane ROCHE holds a PhD in Biological and Medical Engineering and is a former University Hospital Assistant of the Grenoble Hospitals. Stéphane ROCHE also holds a Habilitation to Supervise Research. He has worked … Read More
Quantitative susceptibility mapping as an imaging biomarker for Alzheimer’s disease: The expectations and limitations Yuto Uchida, Hirohito Kan, Keita Sakurai, Kenichi Oishi and Noriyuki Matsukawa Frontiers In Neuroscience, 5 august 2022 Alzheimer’s disease (AD) is the most common type of … Read More
Ihr Partner für Quantitative Susceptibility Mapping in Europa QSM ist ein innovatives, patentiertes Verfahren, das ursprünglich an der Cornell University im Team von Professor Yi Wang entwickelt wurde und das nun von der US-amerikanischen Gesundheitsbehörde FDA für den Einsatz bei … Read More
Brain pathological changes during neurodegenerative diseases and their identification methods: How does QSM perform in detecting this process? Farzaneh Nikparast, Zohreh Ganji, Mohammad Danesh Doust, Reyhane Faraji & Hoda Zare Insights into Imaging volume 13, Article number: 74 (2022) The … Read More
